Table 1.

General characteristics and serum lipid levels between the controls and patients

Characteristic	Controls (n = 539)	Patients		P
		CAD (n = 525)	IS (n = 540)	P 1	P 2	P 3
Male/female	374/165	383/142	390/150	0.223	0.316	0.837
Age, years	63.08 ± 10.76	62.27 ± 10.93	62.81 ± 12.36	0.222	0.702	0.448
Body mass index, kg/m2	22.84 ± 3.51	23.29 ± 3.33	24.75 ± 5.18	0.033	0.048	0.135
Systolic blood pressure, mmHg	133.18 ± 22.95	137.00 ± 23.28	147.54 ± 21.98	0.007	<0.001	<0.001
Diastolic blood pressure, mmHg	79.78 ± 13.03	81.82 ± 14.13	83.71 ± 12.92	0.014	<0.001	0.023
Pulse pressure, mmHg	54.38 ± 17.94	55.86 ± 18.19	63.80 ± 17.98	0.185	<0.001	<0.001
Cigarette smoking, n (%)	220(40.8)	233(44.4)	226(41.9)	0.264	0.757	0.421
Alcohol consumption, n (%)	232(43.0)	220(41.9)	198(36.7)	0.710	0.035	0.090
Total cholesterol, mmol/L	4.70 ± 1.18	4.61 ± 1.18	4.52 ± 1.15	0.217	0.014	0.232
Triglyceride, mmol/L	1.08(0.81)	1.21(0.80)	1.36(0.93)	0.026	<0.001	<0.001
HDL-C, mmol/L	1.48 ± 0.49	1.45 ± 0.51	1.23 ± 0.40	0.267	<0.001	<0.001
LDL-C, mmol/L	2.78 ± 0.93	2.71 ± 0.90	2.68 ± 0.90	0.255	0.083	0.555
Apolipoprotein (Apo) AI, g/L	1.17 ± 0.32	1.15 ± 0.29	1.02 ± 0.22	0.200	<0.001	0.288
ApoB, g/L	0.89 ± 0.23	0.90 ± 0.25	0.89 ± 0.25	0.574	0.882	0.692
ApoAI/ApoB	1.45 ± 1.76	1.37 ± 0.66	1.17 ± 0.61	0.366	0.001	<0.001
Type 2 diabetes mellitus, n (%)	75(13.9)	117(22.3)	116(21.5)	<0.001	0.001	0.751
Hypertension, n (%)	174(32.3)	266(50.7)	289(53.5)	<0.001	<0.001	0.107
Hyperlipidemia, n (%)	198(36.7)	210(40.0)	212(39.3)	0.284	0.415	0.851
Using lipid-lowing drugs, n (%)	0(0)	172(32.8)	150(27.8)	<0.001	<0.001	0.077

CAD coronary artery disease, IS ischemic stroke, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol

P ₁: comparison of CAD and controls; P ₂: comparison of IS and controls; P ₃: comparison of CAD and IS